MENU
+Compare
IDYA
Stock ticker: NASDAQ
AS OF
Sep 17, 04:59 PM (EDT)
Price
$24.45
Change
-$0.27 (-1.09%)
Capitalization
2.17B

IDYA IDEAYA Biosciences Forecast, Technical & Fundamental Analysis

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics... Show more

IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IDYA with price predictions
Sep 16, 2025

Momentum Indicator for IDYA turns negative, indicating new downward trend

IDYA saw its Momentum Indicator move below the 0 level on September 10, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 103 similar instances where the indicator turned negative. In of the 103 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IDYA moved out of overbought territory on September 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for IDYA turned negative on September 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDYA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IDYA broke above its upper Bollinger Band on September 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where IDYA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

IDYA moved above its 50-day moving average on September 09, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IDYA advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 240 cases where IDYA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IDYA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.232) is normal, around the industry mean (20.607). P/E Ratio (0.000) is within average values for comparable stocks, (53.283). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.160). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (303.030) is also within normal values, averaging (333.412).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IDYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IDYA is expected to report earnings to fall 5.74% to -82 cents per share on November 11

IDEAYA Biosciences IDYA Stock Earnings Reports
Q3'25
Est.
$-0.83
Q2'25
Missed
by $0.09
Q1'25
Missed
by $0.14
Q4'24
Missed
by $0.86
Q3'24
Beat
by $0.02
The last earnings report on August 05 showed earnings per share of -87 cents, missing the estimate of -79 cents. With 673.66K shares outstanding, the current market capitalization sits at 2.17B.
A.I. Advisor
published General Information

General Information

an oncology-focused precision medicine company committed to the discovery and development of targeted cancer therapeutics for patient populations selected using molecular diagnostics.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7000 Shoreline Court
Phone
+1 650 443-6209
Employees
124
Web
https://www.ideayabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEIFX11.18N/A
N/A
Invesco Equity and Income R6
TBCUX17.43N/A
N/A
Tweedy, Browne Intl Val II - Ccy UnH
TIRRX11.47N/A
N/A
T. Rowe Price Real Estate I
BGIKX15.19N/A
N/A
Baillie Gifford International Alpha K
SRORX13.83N/A
N/A
Calamos Antetokounmpo Sustainable Eqs R6

IDYA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.77%
IMNM - IDYA
61%
Loosely correlated
-4.11%
SYRE - IDYA
59%
Loosely correlated
-0.13%
NRIX - IDYA
57%
Loosely correlated
-2.65%
CGON - IDYA
57%
Loosely correlated
+3.35%
XENE - IDYA
57%
Loosely correlated
-0.92%
More